Skip to main content
SpringerLink
Log in

The risks to the prostate of testosterone replacement therapy for late-onset hypogonadism “may not be as great as once believed”

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS.Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA: the Journal of the American Medical Association 296: 2351-2361, No. 19, 15 Nov 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The risks to the prostate of testosterone replacement therapy for late-onset hypogonadism “may not be as great as once believed”. React. Wkly. 1130, 5 (2006). https://doi.org/10.2165/00128415-200611300-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611300-00010

Keywords

Search

Navigation